Status:
COMPLETED
A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
Lead Sponsor:
Vistakon Pharmaceuticals
Conditions:
Open-angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
21+ years
Brief Summary
The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle ...
Eligibility Criteria
Inclusion
- willing to comply with investigator's and protocol's instructions
- patients signature on the informed consent document
- open-angle glaucoma or ocular hypertension
- currently prescribed timolol hemihydrate (once a day (QD) or twice a day (BID))or timolol maleate in sorbate QD as monotherapy or as a part of 2-drug therapy in at least one eye
Exclusion
- inability to understand the trial procedures
- inability to give informed consent
- inability to understand, read, or write English
- best corrected visual acuity of 20/200 or worse in each eye
- current moderate to severe infectious or inflammatory condition of the eye or eyelids including
- current moderate to severe dry eye syndrome
- current chronic use of ocular corticosteroids, ocular surgery or intraocular laser surgery to either eye in the prior 3 months
- treated with 3 or more glaucoma medicines in both eye
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00823043
Start Date
January 1 2009
End Date
July 1 2009
Last Update
March 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Care of San Diego
San Diego, California, United States, 92103